Modern radiotherapy for head and neck cancer D Alterio, G Marvaso, A Ferrari, S Volpe, R Orecchia, BA Jereczek-Fossa Seminars in oncology 46 (3), 233-245, 2019 | 217 | 2019 |
Machine learning-based models for prediction of toxicity outcomes in radiotherapy LJ Isaksson, M Pepa, M Zaffaroni, G Marvaso, D Alterio, S Volpe, ... Frontiers in oncology 10, 790, 2020 | 92 | 2020 |
Exploring applications of radiomics in magnetic resonance imaging of head and neck cancer: a systematic review A Jethanandani, TA Lin, S Volpe, H Elhalawani, ASR Mohamed, P Yang, ... Frontiers in oncology 8, 131, 2018 | 92 | 2018 |
Stereotactic body radiation therapy for oligometastatic ovarian cancer: a step toward a drug holiday R Lazzari, S Ronchi, S Gandini, A Surgo, S Volpe, G Piperno, S Comi, ... International Journal of Radiation Oncology* Biology* Physics 101 (3), 650-660, 2018 | 77 | 2018 |
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) BA Jereczek-Fossa, DP Rojas, D Zerini, C Fodor, A Viola, G Fanetti, ... The British journal of radiology 92 (1094), 20180494, 2019 | 67 | 2019 |
Radiotherapy dose–volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry M Kamal, ASR Mohamed, S Volpe, J Zaveri, MP Barrow, GB Gunn, SY Lai, ... Radiotherapy and Oncology 128 (3), 442-451, 2018 | 43 | 2018 |
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra … SG Gugliandolo, M Pepa, LJ Isaksson, G Marvaso, S Raimondi, F Botta, ... European Radiology 31, 716-728, 2021 | 40 | 2021 |
Machine learning applications in head and neck radiation oncology: lessons from open-source radiomics challenges H Elhalawani, TA Lin, S Volpe, ASR Mohamed, AL White, J Zafereo, ... Frontiers in oncology 8, 294, 2018 | 40 | 2018 |
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression D Alterio, G Marvaso, F Maffini, S Gandini, S Chiocca, A Ferrari, L Preda, ... Medical Oncology 34, 1-10, 2017 | 34 | 2017 |
Head and neck cancer radiotherapy amid COVID‐19 pandemic: Report from Milan, Italy D Alterio, S Volpe, G Marvaso, I Turturici, A Ferrari, MC Leonardi, ... Head & Neck 42 (7), 1482-1490, 2020 | 24 | 2020 |
Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity‐modulated radiation therapy M Kamal, ASR Mohamed, CD Fuller, EM Sturgis, FM Johnson, ... Cancer 124 (7), 1415-1427, 2018 | 24 | 2018 |
Patient reported dry mouth: instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors MDA Head, M Kamal, DI Rosenthal, S Volpe, RP Goepfert, AS Garden, ... Radiotherapy and Oncology 126 (1), 75-80, 2018 | 24 | 2018 |
Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach D Alterio, I Turturici, S Volpe, A Ferrari, SW Russell-Edu, B Vischioni, ... Critical Reviews in Oncology/Hematology 155, 103088, 2020 | 23 | 2020 |
Machine learning for head and neck cancer: a safe bet?—a clinically oriented systematic review for the radiation oncologist S Volpe, M Pepa, M Zaffaroni, F Bellerba, R Santamaria, G Marvaso, ... Frontiers in Oncology 11, 772663, 2021 | 21 | 2021 |
Long‐term outcome of re‐irradiation for recurrent or second primary head and neck cancer: A multi‐institutional study of AIRO—Head and Neck working group E Orlandi, P Bonomo, L Ferella, E D'Angelo, M Maddalo, D Alterio, ... Head & Neck 41 (10), 3684-3692, 2019 | 20 | 2019 |
Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating M Kamal, DI Rosenthal, A Batra, S Volpe, B Elgohari, RP Goepfert, ... Radiotherapy and Oncology 133, 35-42, 2019 | 18 | 2019 |
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation BA Jereczek-Fossa, A Surgo, P Maisonneuve, A Maucieri, MA Gerardi, ... La radiologia medica 124, 65-78, 2019 | 16 | 2019 |
A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to … MAM Meheissen, ASR Mohamed, M Kamal, M Hernandez, S Volpe, ... Radiotherapy and Oncology 130, 46-55, 2019 | 16 | 2019 |
Dose–volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis M Kamal, C Rock, S Grant, J Zaveri, RC Granberry, B O'Donnell, ... Radiotherapy and Oncology 149, 142-149, 2020 | 15 | 2020 |
Oligorecurrent prostate cancer and stereotactic body radiotherapy: where are we now? A systematic review and meta-analysis of prospective studies G Marvaso, S Volpe, M Pepa, M Augugliaro, G Corrao, A Biffi, M Zaffaroni, ... European urology open science 27, 19-28, 2021 | 14 | 2021 |